Guangdong Marubi Biotechnology Co. Ltd Financials

Market Capitalization CN¥17.09 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	46.84
Forward PE	37.39
Price to Sales TTM	CN¥5.42
Price to Book MRQ	CN¥4.86
Enterprise to Revenue	4.88
Enterprise to EBITDA	38.68

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	11.60%
Operating Margin	18.62%
Return on Assets TTM	5.13%
Return on Equity TTM	10.32%

Income Statement

Revenue TTM	CN¥3,155,027,968
Revenue per Share TTM	CN¥7.84
Quarterly Revenue Growth	28.00%
Gross Profit TTM	CN¥2,326,974,720
EBITDA	CN¥433,691,300
Net Income to Common TTM	CN¥366,045,024
Diluted EPS TTM	CN¥0.91
Quarterly Earnings Growth YoY	22.10%

Balance Sheet

Total Cash MRQ	CN¥2,084,679,936
Total Cash per Share MRQ	CN¥5.20
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	14.29
Current Ratio MRQ	2.24
Book Value per Share MRQ	CN¥8.77

Cash Flow

Operating Cash Flow TTM	CN¥282,865,472
Levered Free Cash Flow TTM	CN¥-169,349,824

603983 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	401,000,000
Float Shares	77,000,020
Avg 10 Volume	3,459,152
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	80.80%
% Held by Institutions	8.30%

Stock Price Summary

Beta	0.27
Fifty Two Week Low	CN¥20.17
Fifty Two Week High	CN¥56.98
Fifty Two Week Change	40.92%
Day 50 MA	CN¥45.72
Day 200 MA	CN¥35.48

Dividends and Splits

Forward Annual Dividend Rate	CN¥2.00
Forward Annual Dividend Yield	4.69%
Trailing Annual Dividend Rate	CN¥0.50
Trailing Annual Dividend Yield	1.17%
Payout Ratio	84.62%
Dividend Date
Ex Dividend Date	2025-06-10
Last Split Factor
Last Split Date